Literature DB >> 18641458

Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.

Stefania Assereto1, Mauro Mastrototaro, Silvia Stringara, Elisabetta Gazzerro, Paolo Broda, Grazia Paola Nicchia, Maria Svelto, Claudio Bruno, Vincenzo Nigro, M P Lisanti, Antonio Frigeri, Carlo Minetti.   

Abstract

Aquaporin-4 (AQP4) is the major water channel expressed in fast-twitch skeletal muscle fibers. AQP4 is reduced in Duchenne and Becker Muscular Dystrophies, but not in caveolinopathies, thus suggesting an interaction with dystrophin or with members of the dystrophin-glycoprotein complex (DGC) rather than a nonspecific effect due to muscle membrane damage. To establish the role of sarcoglycans in AQP4 decrease occurring in muscular dystrophy, AQP4 expression was analyzed in muscle biopsies from patients affected by Limb Girdle Muscular Dystrophies (LGMDs) 2C-F genetically confirmed. In all the LGMD 2C-F (2alpha-, 1beta-, 2gamma-, 1delta-deficiency), AQP4 was severely decreased. This effect was associated to a marked reduction in alpha1-syntrophin levels. In control muscle AQP4 did not show a direct interaction with any of the four sarcoglycans but, it co-immunoprecipitated with alpha1-syntrophin, indicating that this modular protein may link AQP4 levels with the DGC complex. To determine whether AQP4 expression could be affected in other LGMDs due to the defect of a membrane protein not associated to the dystrophin complex, we examined AQP4 expression in 6 patients affected by dysferlin deficiency genetically confirmed. All the patients displayed a reduction of the water channel, and AQP4 expression appeared to correlate with the severity of the muscle histopathological lesions. However, differently from what observed in the sarcoglycans, alpha1-syntrophin expression was normal or just slightly reduced. These results seem to indicate an additional mechanism of regulation of AQP4 levels in muscle cells. In accordance with a specific effect of membrane muscle disorders, AQP4 protein levels were not changed in 3 mitochondrial and 3 metabolic myopathies. In conclusion, AQP4 expression and membrane localization are markedly reduced in LGMD 2B-2F. The role of AQP4 in the degenerative mechanism occurring in these diseases will be the object of our future research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641458     DOI: 10.4161/cc.7.14.6272

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

Review 1.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

2.  Transient hyperckemia in the setting of neuromyelitis optica (NMO).

Authors:  Rabia Malik; Aaron Lewis; Bruce A C Cree; Julien Ratelade; Andrea Rossi; Alan S Verkman; Andrew W Bollen; Jeffrey W Ralph
Journal:  Muscle Nerve       Date:  2014-09-24       Impact factor: 3.217

3.  Distinct genetic regions modify specific muscle groups in muscular dystrophy.

Authors:  Kayleigh A Swaggart; Ahlke Heydemann; Abraham A Palmer; Elizabeth M McNally
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

Review 4.  Aquaporin expression in normal and pathological skeletal muscles: a brief review with focus on AQP4.

Authors:  Yoshihiro Wakayama
Journal:  J Biomed Biotechnol       Date:  2010-03-21

5.  Aquaporin-4 expression in distal myopathy with rimmed vacuoles.

Authors:  Akihiko Hoshi; Teiji Yamamoto; Saeko Kikuchi; Tomoko Soeda; Keiko Shimizu; Yoshikazu Ugawa
Journal:  BMC Neurol       Date:  2012-04-27       Impact factor: 2.474

6.  Absence of aquaporin-4 in skeletal muscle alters proteins involved in bioenergetic pathways and calcium handling.

Authors:  Davide Basco; Grazia Paola Nicchia; Angelo D'Alessandro; Lello Zolla; Maria Svelto; Antonio Frigeri
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

7.  Development of a Novel Ligand, [C]TGN-020, for Aquaporin 4 Positron Emission Tomography Imaging.

Authors:  Yukihiro Nakamura; Yuji Suzuki; Mika Tsujita; Vincent J Huber; Kenichi Yamada; Tsutomu Nakada
Journal:  ACS Chem Neurosci       Date:  2011-06-27       Impact factor: 4.418

Review 8.  Signaling Mechanisms and Pharmacological Modulators Governing Diverse Aquaporin Functions in Human Health and Disease.

Authors:  Kim Wagner; Lucas Unger; Mootaz M Salman; Philip Kitchen; Roslyn M Bill; Andrea J Yool
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

9.  AQP4-dependent water transport plays a functional role in exercise-induced skeletal muscle adaptations.

Authors:  Davide Basco; Bert Blaauw; Francesco Pisani; Angelo Sparaneo; Grazia Paola Nicchia; Maria Grazia Mola; Carlo Reggiani; Maria Svelto; Antonio Frigeri
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

Review 10.  Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.

Authors:  Dorianna Sandonà; Romeo Betto
Journal:  Expert Rev Mol Med       Date:  2009-09-28       Impact factor: 5.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.